PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $567M
- YoY, 2025
- +35.4%
- 5-year CAGR
- +13.2%
- 10-year CAGR
- +47.1%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $567M | +35.4% |
| 2024 | $419M | +22.6% |
| 2023 | $342M | +43.9% |
| 2022 | $237M | −27.4% |
| 2021 | $327M | +6.9% |
| 2020 | $306M | +129.9% |
| 2019 | $133M | +3.2% |
| 2018 | $129M | −10.5% |
| 2017 | $144M | +85.6% |
| 2016 | $78M | +550.8% |
| 2015 | $12M | +27.9% |
| 2014 | $9.3M | — |